Genasys inc. (LRAD)
CashFlow / Yearly
Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10
Operating Activities:
Net income

2,784

-3,745

-876

-1,281

9,687

3,327

1,262

1,462

5,022

2,983

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

824

483

153

167

238

209

146

93

-

-

Less: Net income from discontinued operations (Note 16)

-

-

-

-

-

-

-

-

69

-49

Net income from continuing operations

-

-

-

-

-

-

-

-

4,953

3,032

Depreciation and amortization

-

-

-

-

-

-

-

-

138

206

Provision for doubtful accounts

-23

150

0

-

-

-3

-0

4

-

-

Warranty provision

85

6

-70

79

-

-

-

-

-

-

Warranty provision

-

-

-

-

42

157

-

-

-

-

Inventory obsolescence

-

-

-

159

65

36

-

-

-

-

Warranty provision

-

-

-

-

-

-

-19

33

-

-

Warranty provision

-

-

-

-

-

-

-

-

74

69

Inventory obsolescence

142

171

26

-

-

-

-143

154

-16

60

Share-based compensation

735

584

1,116

605

619

585

736

684

422

475

Deferred income taxes

570

2,374

196

-188

-8,339

0

-

-

-

-

Gain on disposition of asset

-

-0

0

-

-

-

-

-

-

-

Loss on impairment of patents

-

11

0

-

-

6

86

41

22

47

Changes in operating assets and liabilities:
Unrealized gain on derivative revaluation

-

-

-

-

-

-

-

-

-

747

Restricted cash

-

-

-

-

-

-

-

-606

606

-

Accounts receivable, net

854

-3,149

2,272

1,292

-2,167

-678

-559

424

910

2,754

Inventories, net

-756

1,648

519

-2

1,096

-655

1,331

524

-64

199

Prepaid expenses and other

-1,358

2,075

147

29

41

-479

562

-221

1,160

-

Other assets

-116

60

-226

-187

-187

-148

-187

-116

458

10

Accounts payable

-2,211

192

537

-129

-126

-765

600

-44

75

9

Accrued and other liabilities

-67

127

1,487

51

-2,702

-

-

-

-

-

Warranty settlements

34

11

67

38

41

56

-

-

-

-

Warranty settlements

-

-

-

-

-

-

10

-34

-

-

Warranty settlements

-

-

-

-

-

-

-

-

-47

-72

Accrued and other liabilities

5,671

1,541

-455

556

-526

2,942

205

-2,129

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

1,334

-111

Net cash provided by operating activities

-

-

-

-

135

8,402

-

-

3,886

4

Net cash (used in) provided by operating activities of discontinued operations (Note 17)

-

-

-

-

-

-

-

-

131

365

Net cash used in operating activities

9,855

1,251

-666

-1,149

-

-

1,755

194

4,017

369

Investing Activities:
Purchases of marketable securities

4,495

4,920

2,908

825

4,299

0

-

-

-

-

Proceeds from maturities of marketable securities

4,228

5,190

2,961

0

-

-

-

-

-

-

Capital expenditures

343

625

182

162

344

326

147

-

57

64

Purchase of Genasys, net of cash and restricted cash acquired

-

2,431

-

-

-

-

-

-

-

-

Purchase of Genasys, net of cash and restricted cash acquired

-

-

0

-

-

-

-

-

-

-

Purchased property and equipment

-

-

-

-

-

-

-

201

-

-

Patent costs paid

-

-

-

11

10

14

2

3

2

17

Net cash used in investing activities

-

-

-

-

-4,654

-341

-

-

-

-

Net cash used in investing activities

-610

-2,787

-129

-999

-

-

-150

-205

-60

-81

Financing Activities:
Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

-

4,346

-

Proceeds from exercise of stock options

703

2,434

133

2

504

544

340

-

145

30

Repurchase of common stock

2,171

725

0

1,748

1,564

516

-

-

-

-

Proceeds from the issuance of unsecured promissory notes

-

62

0

-

-

-

-

-

-

-

Payments on promissory notes

17

1,175

0

-

-

-

-

-

-

-

Common stock cash dividends paid

-

-

-

954

0

-

-

-

-

-

Net cash used in financing activities

-

-

-

-

-1,060

28

-

-

-

-

Net cash used in financing activities

-1,484

596

133

-2,700

-

-

340

-

4,492

30

Effect of foreign exchange rate on cash

-49

-59

0

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents, and restricted cash

7,710

-997

-662

-

-

-

-

-

-

-

Net increase in cash

-

-

-

-4,849

-5,578

8,089

1,945

-11

8,449

318

Supplemental disclosures of cash flow information:
Interest paid

2

18

0

-

-

-

-

-

-

-

Noncash investing and financing activities:
Change in unrealized gain (loss) on marketable securities

20

-7

0

-

-

-

-

-

-

-

Fair value of assets acquired

-

5,520

0

-

-

-

-

-

-

-

Cash paid or payable

-

-3,011

0

-

-

-

-

-

-

-

Liabilities assumed

-

2,509

0

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

0

1

Cash paid for taxes

-

-

-

-

-

14

-38

-152

222

104

Reclassification of warrants from equity to a liability

-

-

-

-

-

-

-

-

-

747